STOCKSCOUTER
StockScouter Premium
StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance
Learn more or Get it now! Stockscouter Portfolio performance
SMMT SUMMIT THERAPEUTICS INCORPORATED StockScouter® Report
4
StockScouter® Score
SUMMIT THERAPEUTICS INCORPORATED, a small cap company in the healthcare sector, is expected to slightly outperform the market over the next six months with slightly higher than average risk
10 is the best possible rating. Learn more.
Summary
Positives
- Two or more executives, directors or major shareholders – including one high-level executive -- purchased a large number of shares recently. Very positive
- Moving average analysis for SMMT suggests strong price movement over the medium term. Positive
Concerns
- The enterprise value-to-sales ratio is much higher than the average for comparably-sized companies in the StockScouter universe. Very Negative
- Earnings growth in the past year has decelerated rapidly compared to earnings growth in the past three years. Negative
Short-term Outlook
Over the next 1-2 months, StockScouter forecasts that small cap stocks will be out of favor, stocks will be , and healthcare stocks will be out of favor.
Expected Risk/Return
Core Model Grades
F
A
F
B